We are live on ! Find out more
OVID icon

Ovid Therapeutics
OVID

60 hedge funds and large institutions have $71.7M invested in Ovid Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

9% more capital invested

Capital invested by funds: $65.5M → $71.7M (+$6.19M)

4.17% more ownership

Funds ownership: 50.54% → 54.72% (+4.2%)

2% more funds holding

Funds holding: 59 → 60 (+1)

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

Holders
60
Holders Change
+1
Holders Change %
+1.69%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
11
Reduced
22
Closed
8
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$35K

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$3.94M
2
MAP
Madison Avenue Partners
New York
+$2.26M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$283K
4
E
Ergoteles
New York
+$129K
5
Jane Street
Jane Street
New York
+$76.7K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$2.83M
2
BlackRock
BlackRock
New York
-$741K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$315K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$239K
5
DA
DCF Advisers
Connecticut
-$157K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$4K -$4.45K -2,609 -58%
SSB
52
Sandy Spring Bank
Maryland
$3.72K – – –
CG
53
Cutler Group
California
$3K – – –
Citigroup
54
Citigroup
New York
$2.3K +$73 +43 +4%
Osaic Holdings
55
Osaic Holdings
Arizona
$1K – – –
SOW
56
State of Wyoming
Wyoming
$545 +$370 +217 +286%
IGWM
57
ICA Group Wealth Management
Colorado
$102 +$94 +55 New
Dimensional Fund Advisors
58
Dimensional Fund Advisors
Texas
$67 -$10.2K -6,016 -14%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$2 -$269 -158 -99%
SCM
60
Stonepine Capital Management
Oregon
– -$2.83M -1,540,671 Closed
Balyasny Asset Management
61
Balyasny Asset Management
Illinois
– -$59K -31,938 Closed
VF
62
Virtu Financial
New York
– -$19K -10,347 Closed
American Century Companies
63
American Century Companies
Missouri
– -$19K -10,071 Closed
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
– -$4K -2,000 Closed
Group One Trading
65
Group One Trading
Illinois
– -$3K -1,532 Closed
CUAMC
66
China Universal Asset Management Company
China
– -$1K -660 Closed
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
– -$687 -403 -88%
1 2
3

OVID Hedge Fund Activity: Q4 2022 in Review

60 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Ovid Therapeutics (OVID) for Q4 2022, worth a combined $71.7M — up 9.5% from $65.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OVID positions and 8 closed out — a net gain of 1 holder — while 11 added to existing stakes and 22 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $3.94M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.83M sold.

  • 60 institutional investors held Ovid Therapeutics (OVID) as of Q4 2022, up from 59 in Q3 2022.
  • Funds reported $71.7M of Ovid Therapeutics stock for Q4 2022, up 9.5% quarter-over-quarter.
  • 9 funds opened new Ovid Therapeutics positions in Q4 2022 and 8 closed out, a net change of +1 holder.
  • The largest Ovid Therapeutics buyer in Q4 2022 was Rubric Capital Management (New York), an estimated $3.94M added.
  • The largest Ovid Therapeutics seller in Q4 2022 was Stonepine Capital Management, an estimated $2.83M sold.

Based on aggregated 13F filings for Q4 2022.